178 related articles for article (PubMed ID: 16979657)
21. TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth.
Pavlides SC; Lecanda J; Daubriac J; Pandya UM; Gama P; Blank S; Mittal K; Shukla P; Gold LI
Cell Cycle; 2016; 15(7):931-47. PubMed ID: 26963853
[TBL] [Abstract][Full Text] [Related]
22. Protein-protein interactions involved in the recognition of p27 by E3 ubiquitin ligase.
Xu K; Belunis C; Chu W; Weber D; Podlaski F; Huang KS; Reed SI; Vassilev LT
Biochem J; 2003 May; 371(Pt 3):957-64. PubMed ID: 12529174
[TBL] [Abstract][Full Text] [Related]
23. Loss of cks1 homeostasis deregulates cell division cycle.
Krishnan A; Nair SA; Pillai MR
J Cell Mol Med; 2010 Jan; 14(1-2):154-64. PubMed ID: 19228269
[TBL] [Abstract][Full Text] [Related]
24. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex.
Wei W; Ayad NG; Wan Y; Zhang GJ; Kirschner MW; Kaelin WG
Nature; 2004 Mar; 428(6979):194-8. PubMed ID: 15014503
[TBL] [Abstract][Full Text] [Related]
25. Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation.
Kitajima S; Kudo Y; Ogawa I; Bashir T; Kitagawa M; Miyauchi M; Pagano M; Takata T
Am J Pathol; 2004 Dec; 165(6):2147-55. PubMed ID: 15579456
[TBL] [Abstract][Full Text] [Related]
26. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.
Nakayama K; Nagahama H; Minamishima YA; Matsumoto M; Nakamichi I; Kitagawa K; Shirane M; Tsunematsu R; Tsukiyama T; Ishida N; Kitagawa M; Nakayama K; Hatakeyama S
EMBO J; 2000 May; 19(9):2069-81. PubMed ID: 10790373
[TBL] [Abstract][Full Text] [Related]
27. Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation.
Salamina M; Montefiore BC; Liu M; Wood DJ; Heath R; Ault JR; Wang LZ; Korolchuk S; Baslé A; Pastok MW; Reeks J; Tatum NJ; Sobott F; Arold ST; Pagano M; Noble MEM; Endicott JA
J Mol Biol; 2021 Mar; 433(5):166795. PubMed ID: 33422522
[TBL] [Abstract][Full Text] [Related]
28. Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells.
Uehara N; Yoshizawa K; Tsubura A
Oncol Rep; 2012 Jul; 28(1):105-10. PubMed ID: 22484732
[TBL] [Abstract][Full Text] [Related]
29. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex.
Schulman BA; Carrano AC; Jeffrey PD; Bowen Z; Kinnucan ER; Finnin MS; Elledge SJ; Harper JW; Pagano M; Pavletich NP
Nature; 2000 Nov; 408(6810):381-6. PubMed ID: 11099048
[TBL] [Abstract][Full Text] [Related]
30. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2).
Mamillapalli R; Gavrilova N; Mihaylova VT; Tsvetkov LM; Wu H; Zhang H; Sun H
Curr Biol; 2001 Feb; 11(4):263-7. PubMed ID: 11250155
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study.
Liu Z; Fu Q; Lv J; Wang F; Ding K
J Exp Clin Cancer Res; 2008 Oct; 27(1):51. PubMed ID: 18922157
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2.
Ungermannova D; Gao Y; Liu X
J Biol Chem; 2005 Aug; 280(34):30301-9. PubMed ID: 15980415
[TBL] [Abstract][Full Text] [Related]
33. Role of conformational heterogeneity in domain swapping and adapter function of the Cks proteins.
Seeliger MA; Spichty M; Kelly SE; Bycroft M; Freund SM; Karplus M; Itzhaki LS
J Biol Chem; 2005 Aug; 280(34):30448-59. PubMed ID: 15772084
[TBL] [Abstract][Full Text] [Related]
34. O
Sheikh MO; Thieker D; Chalmers G; Schafer CM; Ishihara M; Azadi P; Woods RJ; Glushka JN; Bendiak B; Prestegard JH; West CM
J Biol Chem; 2017 Nov; 292(46):18897-18915. PubMed ID: 28928219
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor upregulates Skp2/Cks1 and p27(kip1) in human extrahepatic cholangiocarcinoma cells.
Kim JY; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim DH; Chae SW; Sohn JH
World J Gastroenterol; 2014 Jan; 20(3):755-73. PubMed ID: 24574749
[TBL] [Abstract][Full Text] [Related]
36. Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.
Gupta P; Zhao H; Hoang B; Schwartz EL
Br J Cancer; 2022 Oct; 127(6):969-975. PubMed ID: 35752713
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitin-conjugating enzyme Cdc34 and ubiquitin ligase Skp1-cullin-F-box ligase (SCF) interact through multiple conformations.
Sandoval D; Hill S; Ziemba A; Lewis S; Kuhlman B; Kleiger G
J Biol Chem; 2015 Jan; 290(2):1106-18. PubMed ID: 25425648
[TBL] [Abstract][Full Text] [Related]
38. Specific small molecule inhibitors of Skp2-mediated p27 degradation.
Wu L; Grigoryan AV; Li Y; Hao B; Pagano M; Cardozo TJ
Chem Biol; 2012 Dec; 19(12):1515-24. PubMed ID: 23261596
[TBL] [Abstract][Full Text] [Related]
39. Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1.
Hu K; Li XJ; Asmamaw MD; Shi XJ; Liu HM
Sci Rep; 2021 Oct; 11(1):21105. PubMed ID: 34702937
[TBL] [Abstract][Full Text] [Related]
40. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I
J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]